Title Phenotypesort ascending Institution Algorithm Type Total Cases Total Controls PPV Sensitivity
Vanderbilt evaluation for Diverticulosis Diverticulosis and Diverticulitis Vanderbilt University Case Only 0.88
Marshfield diverticulosis/diverticulitis implementation Diverticulosis and Diverticulitis Marshfield Clinic Research Foundation Case, Control 50 50 1.00, 1.00
Network Combined Dataset - Diverticulosis Diverticulosis and Diverticulitis Case, Control 6,173 4,969
Diverticulosis Implementation - Columbia Diverticulosis and Diverticulitis Columbia University Case, Control 66 689
Geisinger eMERGE3 Combined Implementation Diverticulosis and Diverticulitis Geisinger Case, Control 0.97, 0.94
Harvard Implementation Diverticulosis and Diverticulitis Harvard Medical School Case, Control 884 770
VU E3 implementation Diverticulosis and Diverticulitis Vanderbilt University Medical Center Case, Control
Mayo Clinic eMERGE III Implementation Diverticulosis and Diverticulitis Mayo Clinic Case, Control 3,679 2,459
GHUW Diverticulitis Diverticulosis and Diverticulitis GHRI/UW Case, Control
NU e3 Diverticulosis Diverticulosis and Diverticulitis Northwestern University Case, Control 1,273 1,211
VUMC ACEi cough implementation ACE Inhibitor (ACE-I) induced cough Vanderbilt University Case, Control 1.00, 1.00 0.96
Validation of ACEi-induced cough algorithm ACE Inhibitor (ACE-I) induced cough Mayo Clinic Case, Control 1.00, 0.96
NU ACE Inhibitor (ACE-I) induced cough implementation ACE Inhibitor (ACE-I) induced cough Northwestern University The Feinberg School of Medicine Case, Control 1.00, 0.98
Marshfield ACE-I cough implentation ACE Inhibitor (ACE-I) induced cough Marshfield Clinic Research Foundation Case, Control 25 25 1.00, 0.96
Network Combined Dataset - ACE-I induced Cough ACE Inhibitor (ACE-I) induced cough Case, Control
ACEi Cough Implementation - Columbia ACE Inhibitor (ACE-I) induced cough Columbia University Case, Control 17 233
Clopidogrel Poor Metabolizers-Columbia Clopidogrel Poor Metabolizers Columbia University Case Only
Demonstration Project AF Implementation Atrial Fibrillation - Demonstration Project Vanderbilt University Case, Control 0.98, 1.00
Demonstration Project Crohn's Disease Implementation Crohn's Disease - Demonstration Project Vanderbilt University Case, Control 1.00, 1.00
Demonstration Project MS Implementation Multiple Sclerosis - Demonstration Project Vanderbilt University Case, Control 0.87, 1.00
Demonstration Project RA Implementation Rheumatoid Arthritis - Demonstration Project Vanderbilt University Case, Control 0.97, 1.00
Demonstration Project T2D Implementation Type 2 Diabetes - Demonstration Project Vanderbilt University Case, Control 1.00, 1.00
CDiff NU implementation - May 2012 chart review Clostridium Difficile Colitis Northwestern University Case, Control 0.90, 0.95 0.95
Group Health implementation Clostridium Difficile Colitis Group Health Cooperative Case, Control 0.92, 0.88
Vanderbilt implementation Clostridium Difficile Colitis Case, Control 1.00, 1.00

Pages